These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34758977)

  • 1. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.
    Ng K; Stavropoulos H; Anand V; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Hagopian W; Achenbach P;
    Diabetes Care; 2022 Jan; 45(1):160-168. PubMed ID: 34758977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes.
    Nieto J; Castillo B; Astudillo M; Tosur M; Balasubramanyam A; Pietropaolo M; Redondo MJ
    Pediatr Diabetes; 2021 Sep; 22(6):882-888. PubMed ID: 34018301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Mistry S; Gouripeddi R; Raman V; Facelli JC
    Diabetologia; 2023 Mar; 66(3):520-534. PubMed ID: 36446887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
    Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
    Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
    Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
    Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
    Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
    Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.
    Pastore MR; Bazzigaluppi E; Bonfanti R; Dozio N; Sergi A; Balini A; Belloni C; Meschi F; Bonifacio E; Bosi E
    Diabetes Care; 1998 Sep; 21(9):1445-50. PubMed ID: 9727889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.